Machine learning constructs an anaphase-promoting complex (ANAPC) related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma

The anaphase-promoting complex (ANAPC) plays a critical role in tumor cell mitosis. Constructing an ANAPC-related prognostic signature may aid hepatocellular carcinoma (HCC) patient stratification, treatment selection, and follow-up optimization. Transcriptional profiles and clinical data of HCC samples were retrieved from The Cancer Genome Atlas (TCGA). We developed a risk scoring system based on a machine learning algorithm. Moreover, we investigated the oncogenic function of CDC27 in Huh-7 cells. We profiled ANAPC expression, genomic alterations, and prognostic associations in HCC. Patients were stratified into two subgroups with distinct prognostic outcomes based on ANAPC-gene expression. An ANAPC-cluster-derived prognostic signature comprising SPP1, CDCA8 and CFHR4 was subsequently built. The risk score separated high- and low-risk patients with differences in survival, immune-checkpoint expression, immune-cell infiltration, and computationally inferred immunotherapy and drug-sensitivity responses. In vitro assays showed that CDC27 knockdown suppresses proliferation and invasion in Huh-7 cells. In conclusion, we constructed an ANAPC-associated prognostic signature with promising predictive performance for HCC survival, tumor microenvironment, computationally predicted immunotherapy response and drug sensitivity. Our in-vitro data support the oncogenic role of CDC27 in Huh-7 HCC cells.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-11-21
DOI
https://doi.org/10.1186/s12885-026-17420-1
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Machine learning constructs an anaphase-promoting complex (ANAPC) related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma

shousheng Liu, Kunwei Peng, Li Liao, Jiaxin Yang et al.
BMC Cancer
Hepatocellular Carcinoma Treatment and Prognosis
article

Machine learning constructs an anaphase-promoting complex (ANAPC) related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma

shousheng Liu, Kunwei Peng, Li Liao, Jiaxin Yang, Cuirong Tan, Haoqian Song
article en

Abstract

The anaphase-promoting complex (ANAPC) plays a critical role in tumor cell mitosis. Constructing an ANAPC-related prognostic signature may aid hepatocellular carcinoma (HCC) patient stratification, treatment selection, and follow-up optimization. Transcriptional profiles and clinical data of HCC samples were retrieved from The Cancer Genome Atlas (TCGA). We developed a risk scoring system based on a machine learning algorithm. Moreover, we investigated the oncogenic function of CDC27 in Huh-7 cells. We profiled ANAPC expression, genomic alterations, and prognostic associations in HCC. Patients were stratified into two subgroups with distinct prognostic outcomes based on ANAPC-gene expression. An ANAPC-cluster-derived prognostic signature comprising SPP1, CDCA8 and CFHR4 was subsequently built. The risk score separated high- and low-risk patients with differences in survival, immune-checkpoint expression, immune-cell infiltration, and computationally inferred immunotherapy and drug-sensitivity responses. In vitro assays showed that CDC27 knockdown suppresses proliferation and invasion in Huh-7 cells. In conclusion, we constructed an ANAPC-associated prognostic signature with promising predictive performance for HCC survival, tumor microenvironment, computationally predicted immunotherapy response and drug sensitivity. Our in-vitro data support the oncogenic role of CDC27 in Huh-7 HCC cells.

BMC Cancer
Sun Yat-sen University (CN), Guangdong Medical College (CN), Second Affiliated Hospital of Guangzhou Medical University (CN), Sun Yat-sen University Cancer Center (CN), Guangzhou Medical University (CN)
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Machine learning constructs an anaphase-promoting complex (ANAPC) related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma — shousheng Liu, Kunwei Peng, et al. · BMC Cancer (2026) | TGRS Research Map | TGRS